Appian Blog

Be a Part of the Process

Appian Archive

The Future of Pharmaceutical IT Starts Today

The 14th Annual Pharmaceutical IT Congress promised an in-depth look into the future innovations of technology in the life sciences industry, and I have to say, London did not disappoint. On  September 28-29, I joined over 150 pharmaceutical information technology and business specialists as we dove into key topics that are currently top of mind ... Read More

See into the Future of Pharmaceutical IT

It’s no secret, the Pharmaceutical IT industry is growing rapidly. By 2017, IT research experts Ovum, forecast that IT spending in the life sciences industry will reach $40.8 billion globally.   We have learned over the years that the amount of money spent does not mean the optimal solutions are being identified and implemented. Pharmaceutical IT is ... Read More

Accelerate Your Study Start Up and Tracking

When it comes to executing clinical trials, speed is everything. Well executed, speedy clinical trial initiation can result in faster completion of the trial and acceleration of time to market. The sooner a product is released to market, the sooner life saving and life altering medicine is available for patients, and the longer it can ... Read More

How to Automate Clinical, Safety, and Business Processes with Innovative Technology

Safety. Efficiency. Automation. What industry doesn’t need these things to have their business processes run smoothly? Pharmaceutical companies are no different. Except in Pharma, there are even more challenges, especially when it comes to healthcare regulatory compliance, patents, and so much more. Perhaps the biggest challenge? Being first to market. When it comes to efficiency ... Read More

Rolling With the Punches: How to Handle Regulatory Management in Pharma

“The only thing that is constant in life, is change.” The pharmaceuticals industry fits that old saying “to a T.” As the science for getting drugs to consumers changes, so does the regulatory management of this sensitive subject. And that’s where Appian comes in. Appian’s flexible platform for Regulatory Information Management (RIM) allows pharma companies ... Read More

The Future of Knowledge Work

Did you meet Baxter at Appian World 16? Baxter might not be as smart as Lieutenant Commander Data. He’s definitely not as strong as the new FANUC M-2000iA/1700L that can lift 1.7 tons—the equivalent of two small cars or 24 people. And, he is certainly not as pretty as the robot “clones” on Orphan Black. ... Read More

What Sia has to do with RIM

What could pop star Sia possibly have do with Regulatory Information Management? Let’s say you’re in Life Sciences. Pharma, specifically. Let’s also say that you’re hip to new music. Heck…even not hip per se, but you enjoy hearing and learning new stuff. Well then, you may know…or enjoy getting to know Sia. Sia is a singer ... Read More

Attend Appian World’s Life Sciences Industry Breakout with Regulated Regina

Regulated Regina knows her company’s business processes need to be more dynamic and agile so better, faster, and smarter decisions can be made. But, in the life sciences and healthcare industries, accelerating time to market, expediting the availability of new treatments for patients, and preserving patient safety is challenging – especially with complicated regulatory requirements ... Read More

If it’s not documented, did it happen?

If a tree falls in the forest, and no one is there to see or hear it, did it really fall? Well according to FDA rules, and other similar, strict interpretations of health authorities, the answer is an emphatic NO. Even if the inspector can observe the tree on the ground, there would still be doubt ... Read More

Webinar: Strategies for Life Sciences Apps

Is your organization building, using, or considering Life Sciences apps to help manage diseases your products treat? If so, then you may already be aware of the regulatory challenges for designing these types of apps. Life Sciences apps that claim to give medical advice especially face scrutiny of regulations that have been fuzzy at best…until ... Read More